Literature DB >> 7478803

Obesity after successful treatment of acute lymphoblastic leukemia in childhood.

J E Van Dongen-Melman1, A C Hokken-Koelega, K Hählen, A De Groot, C G Tromp, R M Egeler.   

Abstract

Early and late effects of treatment for acute lymphoblastic leukemia (ALL) on weight was retrospectively investigated in 113 children in continuous first remission. Weight was examined at diagnosis up to 10 y after cessation of treatment. There was an increased prevalence of overweight after treatment for ALL which persisted over time. All treatment regimens included corticosteroid therapy, and 52 patients received additional cranial irradiation. Patients treated with and without cranial irradiation did not differ in weight gain, indicating that not cranial irradiation but corticosteroid therapy might explain weight gain in children treated for ALL. Dexamethasone was associated with a significant increase of weight at cessation of treatment. Patients treated with a combination of prednisone and dexamethasone had as a late effect the highest prevalence of obesity (44%). Gender or age at diagnosis were not related to weight gain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478803     DOI: 10.1203/00006450-199507000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  31 in total

1.  Pitfalls in the assessment of body composition in survivors of acute lymphoblastic leukaemia.

Authors:  J T Warner; W D Evans; D K H Webb; J W Gregory
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

2.  Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.

Authors:  Sogol Mostoufi-Moab; Jill P Ginsberg; Nancy Bunin; Babette S Zemel; Justine Shults; Meena Thayu; Mary B Leonard
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

3.  Characteristics and determinants of adiposity in pediatric cancer survivors.

Authors:  Tracie L Miller; Stuart R Lipsitz; Gabriela Lopez-Mitnik; Andrea S Hinkle; Louis S Constine; M Jacob Adams; Carol French; Cynthia Proukou; Amy Rovitelli; Steven E Lipshultz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

Review 4.  Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.

Authors:  Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger
Journal:  Lancet Diabetes Endocrinol       Date:  2015-04-12       Impact factor: 32.069

5.  Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia.

Authors:  Rajesh R Nair; Werner J Geldenhuys; Debbie Piktel; Prabodh Sadana; Laura F Gibson
Journal:  Bioorg Med Chem Lett       Date:  2018-03-23       Impact factor: 2.823

Review 6.  Obesity in pediatric ALL survivors: a meta-analysis.

Authors:  Fang Fang Zhang; Michael J Kelly; Edward Saltzman; Aviva Must; Susan B Roberts; Susan K Parsons
Journal:  Pediatrics       Date:  2014-02-17       Impact factor: 7.124

7.  Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia.

Authors:  N H Birkebaek; N Clausen
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

8.  Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity?

Authors:  H Jansen; A Postma; R P Stolk; W A Kamps
Journal:  Support Care Cancer       Date:  2008-11-07       Impact factor: 3.603

9.  Trends in Obesity Prevalence in Adults With a History of Cancer: Results From the US National Health Interview Survey, 1997 to 2014.

Authors:  Heather Greenlee; Zaixing Shi; Christine L Sardo Molmenti; Andrew Rundle; Wei Yann Tsai
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

10.  Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.

Authors:  Eric J Chow; Catherine Pihoker; Debra L Friedman; Stephanie J Lee; Jeannine S McCune; Claire Wharton; Christian L Roth; K Scott Baker
Journal:  Pediatr Blood Cancer       Date:  2012-10-05       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.